DEA schedule

Is lisdexamfetamine a controlled substance?

Federal schedule for lisdexamfetamine from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

Yes. Lisdexamfetamine is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Lisdexamfetamine (Schedule II).

Run it in Rivvi

Which 2027 plans near you dropped or restricted lisdexamfetamine?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Lisdexamfetamine
SourceWhat it lists
FDA NDC directory178 prescription listings from 21 labelers, all Schedule II
DEA controlled substances listLisdexamfetamine: Schedule II

DEA list entry

DEA list entries for lisdexamfetamine
SubstanceDEA codeScheduleNarcoticOther namesMatch
Lisdexamfetamine1205IINoVyvanseListed by name

Lisdexamfetamine NDC listings

NDC listings for Lisdexamfetamine
NDCProductFormStrengthLabelerDEA schedule
24338-019ARYNTAsolution10 mg/mLAzurity Pharmaceuticals, Inc.CII
24338-103ARYNTAsolution10 mg/mLAzurity Pharmaceuticals, Inc.CII
24338-109ARYNTAsolution10 mg/mLAzurity Pharmaceuticals, Inc.CII
24338-160ARYNTAsolution10 mg/mLAzurity Pharmaceuticals, Inc.CII
24338-162ARYNTAsolution10 mg/mLAzurity Pharmaceuticals, Inc.CII
59417-101Vyvansecapsule10 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-102Vyvansecapsule20 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-103Vyvansecapsule30 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-104Vyvansecapsule40 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-105Vyvansecapsule50 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-106Vyvansecapsule60 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-107Vyvansecapsule70 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-115Vyvansetablet, chewable10 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-116Vyvansetablet, chewable20 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-117Vyvansetablet, chewable30 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-118Vyvansetablet, chewable40 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-119Vyvansetablet, chewable50 mg/1Takeda Pharmaceuticals America, Inc.CII
59417-120Vyvansetablet, chewable60 mg/1Takeda Pharmaceuticals America, Inc.CII
0054-0660Lisdexamfetamine Dimesylatecapsule10 mg/1Hikma Pharmaceuticals USA Inc.CII
0378-6854Lisdexamfetamine Dimesylatecapsule10 mg/1Mylan Pharmaceuticals Inc.CII
0406-5111Lisdexamfetamine Dimesylatecapsule10 mg/1SpecGx LLCCII
0480-3565Lisdexamfetamine dimesylatecapsule10 mg/1Teva Pharmaceuticals, Inc.CII
0527-4661Lisdexamfetamine Dimesylatecapsule10 mg/1Lannett Company, LLCCII
0781-2299Lisdexamfetamine dimesylatecapsule10 mg/1Sandoz IncCII
31722-350LISDEXAMFETAMINE DIMESYLATEcapsule10 mg/1Camber Pharmaceuticals, Inc.CII
42858-161LISDEXAMFETAMINE DIMESYLATEcapsule10 mg/1Rhodes Pharmaceuticals LLCCII
43547-602Lisdexamfetamine dimesylatecapsule10 mg/1Solco Healthcare US,LLCCII
47781-562lisdexamfetamine dimesylatecapsule10 mg/1Alvogen Inc.CII
57664-046LISDEXAMFETAMINE DIMESYLATEcapsule10 mg/1Sun Pharmaceutical Industries, Inc.CII
60505-4739Lisdexamfetamine Dimesylatecapsule10 mg/1Apotex Corp.CII
64850-550Lisdexamfetamine Dimesylatecapsule10 mg/1Elite Laboratories, Inc.CII
70010-206LISDEXAMFETAMINE DIMESYLATEcapsule10 mg/1Granules Pharmaceuticals Inc.CII
72162-2451LISDEXAMFETAMINE DIMESYLATEcapsule10 mg/1Bryant Ranch PrepackCII
0054-0370Lisdexamfetamine Dimesylatecapsule20 mg/1Hikma Pharmaceuticals USA Inc.CII
0378-6855Lisdexamfetamine Dimesylatecapsule20 mg/1Mylan Pharmaceuticals Inc.CII
0406-5112Lisdexamfetamine Dimesylatecapsule20 mg/1SpecGx LLCCII
0480-3566Lisdexamfetamine dimesylatecapsule20 mg/1Teva Pharmaceuticals, Inc.CII
0527-4662Lisdexamfetamine Dimesylatecapsule20 mg/1Lannett Company, LLCCII
0781-2476Lisdexamfetamine dimesylatecapsule20 mg/1Sandoz IncCII
31722-351LISDEXAMFETAMINE DIMESYLATEcapsule20 mg/1Camber Pharmaceuticals, Inc.CII

Showing 40 of 178 listings.

Questions

Is lisdexamfetamine a controlled substance?

Yes. Lisdexamfetamine is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Lisdexamfetamine (Schedule II).

Is lisdexamfetamine a narcotic?

No. The DEA list does not mark lisdexamfetamine as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.

What schedule is lisdexamfetamine?

Lisdexamfetamine is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Lisdexamfetamine

Try it on your own data today.

Free to start. Most teams are using it the same day.